Ferring VP steps down as chair of API manufacturer
Shortly after Ferring subsidiary Syntese A/S brought in a new CEO from Novo Nordisk, the company bids farewell to its chair, Marienne Kock, senior vice president and general manager at Ferring Denmark. Syntese supplies firms worldwide with the active pharmaceutical ingredient (API), mesalazine.
by MIKKEL AABENHUS HEMMINGSEN, translated by daniel pedersen
A Ferring Pharmaceuticals subsidiary, Syntese A/S, has in a brief period changed out both its CEO and chair of the board of directors, according to the Danish Central Business Register (CVR).
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk executive joins board of Finnish Orion
For subscribers
